X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sterling Biotech with PLETHICO PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs PLETHICO PHARMA - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STERLING BIOTECH PLETHICO PHARMA STERLING BIOTECH/
PLETHICO PHARMA
 
P/E (TTM) x -0.8 -1.1 - View Chart
P/BV x 0.0 0.0 175.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 STERLING BIOTECH   PLETHICO PHARMA
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
PLETHICO PHARMA
Mar-14
STERLING BIOTECH/
PLETHICO PHARMA
5-Yr Chart
Click to enlarge
High Rs11395 2.7%   
Low Rs331 10.9%   
Sales per share (Unadj.) Rs26.8604.4 4.4%  
Earnings per share (Unadj.) Rs-15.032.5 -46.1%  
Cash flow per share (Unadj.) Rs-5.551.3 -10.6%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.9473.6 11.6%  
Shares outstanding (eoy) m267.8734.08 786.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.30.4 73.5%   
Avg P/E ratio x-0.56.6 -7.1%  
P/CF ratio (eoy) x-1.34.2 -30.6%  
Price / Book Value ratio x0.10.5 28.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8627,262 25.6%   
No. of employees `0001.4NA-   
Total wages/salary Rs m5471,596 34.3%   
Avg. sales/employee Rs Th5,303.3NM-  
Avg. wages/employee Rs Th403.8NM-  
Avg. net profit/employee Rs Th-2,959.0NM-  
INCOME DATA
Net Sales Rs m7,18120,598 34.9%  
Other income Rs m43386 11.0%   
Total revenues Rs m7,22320,984 34.4%   
Gross profit Rs m9472,818 33.6%  
Depreciation Rs m2,543642 396.0%   
Interest Rs m4,3771,593 274.7%   
Profit before tax Rs m-5,931969 -612.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924-138 1,390.6%   
Profit after tax Rs m-4,0071,107 -362.0%  
Gross profit margin %13.213.7 96.4%  
Effective tax rate %32.4-14.3 -227.1%   
Net profit margin %-55.85.4 -1,038.3%  
BALANCE SHEET DATA
Current assets Rs m14,33518,877 75.9%   
Current liabilities Rs m49,80911,896 418.7%   
Net working cap to sales %-494.033.9 -1,457.8%  
Current ratio x0.31.6 18.1%  
Inventory Days Days40336 1,122.5%  
Debtors Days Days171198 86.3%  
Net fixed assets Rs m55,4329,861 562.2%   
Share capital Rs m268341 78.6%   
"Free" reserves Rs m13,93512,331 113.0%   
Net worth Rs m14,70116,139 91.1%   
Long term debt Rs m9,4784,706 201.4%   
Total assets Rs m73,98833,146 223.2%  
Interest coverage x-0.41.6 -22.1%   
Debt to equity ratio x0.60.3 221.1%  
Sales to assets ratio x0.10.6 15.6%   
Return on assets %0.58.1 6.1%  
Return on equity %-27.36.9 -397.4%  
Return on capital %-6.412.3 -52.3%  
Exports to sales %25.921.4 121.2%   
Imports to sales %0.215.2 1.1%   
Exports (fob) Rs m1,8604,402 42.2%   
Imports (cif) Rs m123,136 0.4%   
Fx inflow Rs m1,8604,402 42.2%   
Fx outflow Rs m253,184 0.8%   
Net fx Rs m1,8351,219 150.6%   
CASH FLOW
From Operations Rs m1,7192,437 70.5%  
From Investments Rs m-3,148-6,265 50.3%  
From Financial Activity Rs m1,4262,490 57.3%  
Net Cashflow Rs m-3-1,337 0.3%  

Share Holding

Indian Promoters % 33.9 82.7 41.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.3 -  
FIIs % 9.9 5.5 180.0%  
ADR/GDR % 16.9 0.0 -  
Free float % 39.3 7.5 524.0%  
Shareholders   21,482 10,665 201.4%  
Pledged promoter(s) holding % 55.9 85.7 65.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STERLING BIOTECH With:   SANOFI INDIA  TORRENT PHARMA  FRESENIUS KABI ONCO.  WYETH LTD  ABBOTT INDIA  

Compare STERLING BIOTECH With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Cheap Valuation of PSU Banks and Key Stocks in Action Today(Pre-Open)

NSE PSU Bank Index surged 30% on 25th October 2017-the date when bank recapitalization of Rs 2.1 trillion was announced.

Related Views on News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

Tata Chem: Suspension of Haldia Operations Drag Bottomline Lower (Quarterly Results Update - Detailed)

Aug 17, 2017

Interruption at Haldia plant and fire at Lostock facility hits operations during the quarter.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


May 14, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH - GSK PHARMA COMPARISON

COMPARE STERLING BIOTECH WITH

MARKET STATS